IRIS
CLERICO, ALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 53.962
EU - Europa 34.588
AS - Asia 21.007
SA - Sud America 3.512
AF - Africa 407
Continente sconosciuto - Info sul continente non disponibili 203
OC - Oceania 32
Totale 113.711
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 52.626
GB - Regno Unito 14.485
SG - Singapore 7.799
RU - Federazione Russa 6.676
CN - Cina 6.020
UA - Ucraina 3.966
VN - Vietnam 3.117
BR - Brasile 2.817
DE - Germania 2.431
IT - Italia 2.324
HK - Hong Kong 1.925
CA - Canada 1.022
FI - Finlandia 933
SE - Svezia 914
FR - Francia 865
DK - Danimarca 784
PL - Polonia 639
IN - India 371
BD - Bangladesh 323
IL - Israele 272
AR - Argentina 242
IE - Irlanda 203
EU - Europa 202
MX - Messico 199
ZA - Sudafrica 154
TR - Turchia 150
IQ - Iraq 145
ID - Indonesia 140
EC - Ecuador 110
JP - Giappone 96
VE - Venezuela 92
PK - Pakistan 88
CO - Colombia 86
NL - Olanda 85
SA - Arabia Saudita 67
CL - Cile 61
ES - Italia 61
KR - Corea 61
UZ - Uzbekistan 61
MA - Marocco 56
MY - Malesia 50
PH - Filippine 43
RO - Romania 38
AE - Emirati Arabi Uniti 35
PY - Paraguay 35
JO - Giordania 34
TN - Tunisia 34
KE - Kenya 33
LT - Lituania 33
UY - Uruguay 32
EG - Egitto 30
NP - Nepal 29
AT - Austria 25
DZ - Algeria 25
AU - Australia 22
JM - Giamaica 22
ET - Etiopia 21
AZ - Azerbaigian 18
PE - Perù 18
SK - Slovacchia (Repubblica Slovacca) 18
IR - Iran 15
TH - Thailandia 15
KZ - Kazakistan 14
PA - Panama 14
TT - Trinidad e Tobago 14
NI - Nicaragua 13
OM - Oman 13
RS - Serbia 13
BH - Bahrain 12
BO - Bolivia 12
TW - Taiwan 12
AL - Albania 11
DO - Repubblica Dominicana 11
PS - Palestinian Territory 11
HN - Honduras 10
BY - Bielorussia 9
CR - Costa Rica 9
CZ - Repubblica Ceca 9
LB - Libano 9
PT - Portogallo 9
BE - Belgio 8
CI - Costa d'Avorio 8
KW - Kuwait 8
NG - Nigeria 8
NZ - Nuova Zelanda 8
QA - Qatar 8
AM - Armenia 7
AO - Angola 7
BG - Bulgaria 7
HR - Croazia 7
SN - Senegal 7
BB - Barbados 6
CH - Svizzera 6
KH - Cambogia 6
PR - Porto Rico 6
BA - Bosnia-Erzegovina 5
HU - Ungheria 5
KG - Kirghizistan 5
SV - El Salvador 5
BW - Botswana 4
Totale 113.629
Salva come PNG Salva come JPEG
Città #
Southend 12.638
Dallas 8.298
Woodbridge 5.122
Ann Arbor 4.000
Singapore 3.503
Chandler 3.260
Houston 3.012
San Jose 2.718
San Mateo 2.512
Beijing 2.387
Ashburn 2.192
Dearborn 1.956
Jacksonville 1.926
Hong Kong 1.824
Falls Church 1.474
Moscow 1.402
Fairfield 1.187
The Dalles 1.150
Seattle 1.062
Cambridge 948
Wilmington 835
Dong Ket 828
Stevenage 762
Portsmouth 693
Hefei 689
Boardman 664
Warsaw 623
Lawrence 611
Ho Chi Minh City 562
Lauterbourg 560
Brooklyn 525
Los Angeles 512
Pisa 469
Ottawa 459
Chicago 417
Hanoi 398
Santa Clara 302
Helsinki 297
New York 277
São Paulo 269
Buffalo 253
Tel Aviv 249
Council Bluffs 220
Montréal 195
Dublin 189
Old Bridge 185
Salt Lake City 176
San Diego 138
Beauharnois 107
Mexico City 101
Redwood City 101
Rio de Janeiro 100
Munich 99
Rome 99
Norwalk 95
Orem 93
Montreal 90
London 88
Tampa 87
Johannesburg 86
Milan 86
Da Nang 85
Chennai 83
Tokyo 82
Elk Grove Village 73
Stockholm 68
Haiphong 64
Belo Horizonte 60
Phoenix 60
Atlanta 57
Denver 57
Tashkent 54
Baghdad 51
Brasília 51
San Francisco 51
Dhaka 50
Frankfurt am Main 50
Boston 49
Curitiba 49
Toronto 48
Porto Alegre 45
Guangzhou 43
Hải Dương 42
Amsterdam 40
Fremont 39
Poplar 39
Istanbul 38
Augusta 37
Bologna 37
Manchester 37
Biên Hòa 36
Kansas City 36
Quito 36
Nuremberg 35
Seoul 35
Washington 35
Ankara 34
Jeddah 33
Lancaster 33
Shanghai 33
Totale 78.045
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.691
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 690
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 458
siRNA-mediated targeting of endothelial VWF prevents ET-1 upregulation in porcine aortic endothelial cells chronically exposed to angiotensin II 438
Downregulation of von Willebrand Factor prevents Ang II-induced endothelin-1 expression independently of eNOS activation in porcine endothelial cells 410
Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells. 400
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 340
A chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using quality control sera assayed in an interlaboratory survey 338
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 331
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 323
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 322
125I-Endothelin-1 binding sites in human cardiac tissue 320
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study 319
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 319
Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients with Stable Angina 319
Abnormal circulating levels of muscle enzymes and myoglobin in hypothyroidism: their significance and usefulness in follow-up of replacement therapy of the metabolic disorder 313
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 312
A chromatographic method for the determination of uric acid turnover in man 308
A sensitive and accurate plasma noradrenaline assay using a modified fluorimetric method. 301
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 299
A new immunoradiometric assay for the measurement of N-terminal fragment of proatrial natriuretic peptide in human plasma: relationship with atrial and brain natriuretic peptides 298
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 298
A ligand-receptor binding assay of urinary and circulating endogenous digitalis-like factors 291
A simplified method of measuring free triiodothyronine in serum by conbined equilibrium dialysis and gel Sephadex extraction 288
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 288
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 286
A chromatographic method for the determination of uric acid turnover in man 286
Acute effects of intravenous amiodarone administration on thyroid function in arrhthmic patients 283
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 283
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 279
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 278
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 278
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 276
Direct comparison of B-Type Natriuretic Peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data 273
A false positive case of cardiac troponin I: Which diagnostic approach? 273
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 271
A new chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using QC sera assayed in an interlaboratory survey 267
Marcatori di rimodellamento e fibrosi cardiaca 266
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 265
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 265
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 265
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 263
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 261
A simple, sensitive and rapid radioimmunoassay for measurement of urinary albumin 261
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 260
B-type natriuretic peptide secretion following scuba diving 259
Acute effects of intravenous amiodarone administration on thyroid function in arrhthmic patients 259
Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients 257
A rapid procedure for the quantization of natriuretic peptide RNAs by competitive RT-PCR in congenital heart defects 257
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 252
Acute effects of intravenous amiodarone on sulphate metabolite of thyroid hormones in arrhythmic patients 252
Inibizione dell'asse ipofiso-gonadale dopo trattamento con un farmaco anabolizzante (Metandrostenolone, Dianabol) 251
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 247
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 247
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance 245
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 245
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 242
Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones 241
Methodological assessment of mitochondrial respiratory chain-enzyme activities in cardiac tissue 241
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 239
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences 239
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 238
Criteri per la valutazione delle caratteristiche analitiche e della utilità clinica dei nuovi biomarcatori cardiaci 238
The 99th percentile of reference population for cTnI and cTnT assay: Methodology, pathophysiology and clinical implications 238
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 237
Evaluation of analytical performances using standardized analytical protocols and comparison of clinical results of the new ADVIA BNP and NT-proBNP immunoassays for the Centaur XPT platform 237
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 236
Evaluation of analytical performance of immunoassay methods for cTnI and cTnT: From theory to practice 236
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 235
N-terminal fragment of brain natriuretic peptide predicts vascular health and subclinical atherosclerosis: results from MEHLP study 234
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 234
No variation in Hsp70 mRNA level during cardiac surgery in pediatric patients evaluated by semiquantitative RT-PCR 232
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 232
Proposta per l’utilizzo in Pronto Soccorso delle troponine cardiache misurate con metodi di ultima generazione in pazienti con sospetto di sindrome coronarica acuta senza sopraslivellamento del tratto ST 230
Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin i 230
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 230
The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery 229
Evaluation and Comparison with Other High-Sensitivity Methods of Analytical Performance and Measured Values of a New Laboratory Test for Cardiac Troponin I Assay 227
Natriuretic peptide testing in primary care patients. 227
S-nitrosoglutathione as a substrate of gamma-glutamyltransferase (GGT)- A kinetic study 227
BNP values in the first days of life measured with an automated immunoassay platform 226
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 226
Cardiac troponins as biomarkers for cardiac disease 226
Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty 225
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review 225
Comparison of two BNP immunoassays using the same antibodies and standard materials 225
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 224
Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. 223
Genomic medicine and thrombotic risk: who, when, how and why? 222
New biomarkers for risk stratifications in patients with heart failure: high-sensitivity troponin I and galectin-3 222
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training. 221
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 221
Gamma-glumamyl-transferase levels are associated with inflammatory activation, myocardial dysfunction and mortality in pateints with ST-elevation myocardial infarction 221
Prognostic complexity of heart failure and network analysis: the holistic risk stratification 219
Circulating forms of the B-type natriuretic peptide prohormone: pathophysiologic and clinical considerations 218
Plasma gamma-glutamyltransferase fractions: diagnostic and prognostic predictive value 218
Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia. 217
Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases 217
Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. 216
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 216
Totale 28.281
Salva come PNG Salva come JPEG
Categoria #
all - tutte 535.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 535.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.716 0 0 0 0 0 0 0 0 0 0 1.035 1.681
2021/20228.252 276 1.896 208 966 62 55 887 1.779 511 924 56 632
2022/20236.603 616 117 70 1.176 1.151 1.248 12 531 1.101 143 267 171
2023/20241.761 370 85 290 104 72 276 232 72 25 47 29 159
2024/202516.831 116 65 1.084 346 275 1.163 2.348 5.046 1.570 1.069 2.463 1.286
2025/202634.106 1.629 7.932 3.339 3.207 3.369 2.012 6.125 1.660 1.684 2.521 628 0
Totale 113.936